Previous close | 0.6000 |
Open | N/A |
Bid | 0.0000 |
Ask | 0.0500 |
Strike | 165.00 |
Expiry date | 2024-06-21 |
Day's range | 0.6000 - 0.6000 |
Contract range | N/A |
Volume | |
Open interest | 2 |
Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative life science mega campuses in AAA innovation cluster locations, today announced that a top 20 pharmaceutical company and longstanding credit tenant has increased its San Diego footprint by nearly 53% with the execution of a 10-year lease for 127,382 RSF, with significant expansion options, for a new R&D center at 10075 Barnes Canyon Road on the S
Alexandria (ARE) is likely to benefit from the solid demand for top-quality life science assets in key markets. However, a vast development outlay amid high interest rates is concerning.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Alexandria Real Estate Equities (ARE) have what it takes? Let's find out.